August 11th, 2021South Africa’s slow vaccination programme should get a boost from the highly encouraging results of the Sisonke clinical trial of the single-dose Johnson & Johnson...
Following treatment with the Johnson & Johnson vaccine, only 2% of breakthrough infections are severe, according to data in the Sisonke investigation
The SA...
June 9th, 2021The Sisonke Phase 3b clinical trial of the Johnson & Johnson COVID-19 vaccine, during which an impressive nearly 290,000 frontline South African health workers were...
The high rate of HIV infections in South Africa has left Health Minister Dr Aaron Motsoaledi “scared”. City Press reports that Motsoaledi was addressing a discussion...Weekly Roundup
SA's newly published National Strategic Plan (NSP) for HIV, TB and STIs 2017 – 2022 does not acknowledge the country's healthcare dysfunction, nor of the fact...Weekly Roundup
South Africa's recently released HIV plan will help to guide the country's response to everything from sex work, drug use and treatment for the next five years. But,...
